Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma
Aging · 2023
DOI: 10.18632/aging.204535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Guoxiang Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Radiotherapy, Yantaishan Hospital, Yantai 264025, Shandong, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Our study aimed to observe the correlation between epidermal growth factor receptor (EGFR) and programmed cell death-ligand 1 (PD-L1) expression and evaluate prognostic potential of their co-expression in esophageal squamous cell carcinoma (ESCC) patients. EGFR and PD-L1 expression were evaluated by immunohistochemical analysis. We revealed that there was a positive correlation between EGFR and PD-L1 expression in ESCC (P = 0.004). According to the positive relationship between EGFR and PD-L1, all patients were divided into four groups: EGFR (+)/PD-L1 (+), EGFR (+)/PD-L1 (-), EGFR (-)/PD-L1 (+), and EGFR (-)/PD-L1 (-). In 57 ESCC patients without surgery, we found that EGFR and PD-L1 co-expression were statistically correlated with a lower objective response rate (ORR) (p = 0.029), overall survival (OS) (p = 0.018) and progression-free survival (PFS) (p = 0.045) than those with one or none positive protein. Furthermore, PD-L1 expression has a significant positive correlation with infiltration level of 19 immune cells, EGFR expression was significantly correlated with infiltration level of 12 immune cells. The infiltration level of CD8 T cell and B cell were negatively correlated with EGFR expression. On the contrary with EGFR, the infiltration level of CD8 T cell, and B cell were positively correlated with PD-L1 expression. In conclusion, EGFR and PD-L1 co-expression could predict poor ORR and survival in ESCC without surgery, indicating a subset of patients who may benefit from a combination of targeted therapy against EGFR and PD-L1, which may expand the population benefiting from immunotherapy and reduce the occurrence of hyper progressive diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology Radiotherapy, Yantaishan Hospital, Yantai 264025, Shandong, China.
- Department of Oncology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264000, Shandong, China.
- Department of Radiation Oncology, Binzhou Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China.
- Department of Pathology, The First Hospital of Zibo, Zibo 255200, Shandong, China.
- Department of Radiation Oncology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 26400, Shandong, China.
Zitieren
APA
Jiang, G., Miao, Y., Wang, Z., Zhang, Q., Zhou, P., & Zhang, F. (2023). Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma. Aging. https://doi.org/10.18632/aging.204535
Vancouver
Jiang G, Miao Y, Wang Z, Zhang Q, Zhou P, Zhang F. Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma. Aging. 2023. doi:10.18632/aging.204535
BibTeX
@article{Jiang2023,
author = {Jiang, Guoxiang and Miao, Yandong and Wang, Zhenbo and Zhang, Qi and Zhou, Ping and Zhang, Fang},
title = {Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204535}
}
EUVIMED